Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Deferasirox
- Therapeutic area
- Hematology & thrombosis
- Drug class
- Iron chelators
- ATC
- V03AC
- Strength
- 400 mg
- Dosage form
- Tablet
- Pack
- 30's
- Registration no.
- 075072
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Global Pharmaceuticals (Pvt.) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Xefra 400 mg tablet
Xefra 400 mg tablet contains Deferasirox 400 mg. It is registered with DRAP by Global Pharmaceuticals (Pvt.) Ltd (registration no. 075072). Its official price is PKR 19,037.00 for a pack of 30's, about PKR 634.57 per tablet. This price has applied since 27 July 2026. Xefra is also available as 125 mg dispersible tablet, 250 mg dispersible tablet and 500 mg dispersible tablet. No other brand of Deferasirox 400 mg in this form is listed in Pakistan.
Other strengths of Xefra
Official price over time
No change in the official DRAP price is recorded for this pack (30's). Current price PKR 19,037.00, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Xefra 400 mg, 30's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/xefra-400-mg-075072-30s-global-pharmaceuticals-pvt-ltd/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 19,037.00 | 2026-07-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 075072Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
